News + Filings Transactions Holdings
All 13F 13D/G Other
|
Redmile Group, LLC
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/08/2023 |
SC 13G/A
| Redmile Group, LLC reports a 0% stake in OLD AYALA, Inc. |
02/03/2023 |
SC 13G/A
| Redmile Group, LLC reports a 9.7% stake in Stoke therapeutics, Inc. |
11/18/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
11/18/2022 |
SC 13G/A
| Redmile Group, LLC reports a 9.9% stake in Replimune Group, Inc. |
07/18/2022 |
SC 13G/A
| Redmile Group, LLC reports a 9.9% stake in ANNEXON, Inc. |
06/27/2022 |
SC 13G/A
| Redmile Group, LLC reports a 9.9% stake in Scholar Rock Holding Corporation |
02/14/2022 |
SC 13G/A
| Redmile Group, LLC reports a 4.6% stake in Akero Therapeutics, Inc. |
02/14/2022 |
SC 13G/A
| Redmile Group, LLC reports a 10% stake in Amicus Therapeutics, Inc. |
02/14/2022 |
SC 13G/A
| Redmile Group, LLC reports a 9.9% stake in AYALA PHARMACEUTICALS, Inc. |
02/14/2022 |
SC 13G/A
| Redmile Group, LLC reports a 8.5% stake in IMMUNOGEN, INC. |
02/14/2022 |
SC 13G/A
| Redmile Group, LLC reports a 7.3% stake in Krystal Biotech, Inc. |
02/14/2022 |
SC 13G/A
| Redmile Group, LLC reports a 10.9% stake in lAVA THERAPEUTICS N.V. |
02/14/2022 |
SC 13G/A
| Redmile Group, LLC reports a 9.9% stake in NEOLEUKIN THERAPEUTICS, INC. |
02/14/2022 |
SC 13G/A
| Redmile Group, LLC reports a 9.9% stake in Replimune Group, Inc. |
02/14/2022 |
SC 13G/A
| Redmile Group, LLC reports a 9.9% stake in Scholar Rock Holding Corporation |
02/14/2022 |
SC 13G/A
| Redmile Group, LLC reports a 9.1% stake in STEREOTAXIS, Inc. |
02/14/2022 |
SC 13G/A
| Redmile Group, LLC reports a 3.5% stake in Epizyme, Inc |
02/14/2022 |
SC 13G/A
| Redmile Group, LLC reports a 2.6% stake in Atreca, Inc. |
02/14/2022 |
SC 13G/A
| Redmile Group, LLC reports a 9.9% stake in ATARA BIOTHERAPEUTICS, INC. |
02/14/2022 |
SC 13G/A
| Redmile Group, LLC reports a 6.1% stake in STOKE THERAPEUTICS, INC. |
02/14/2022 |
SC 13G/A
| Redmile Group, LLC reports a 0.6% stake in Yumanity Therapeutics, Inc. |
02/14/2022 |
SC 13G/A
| Redmile Group, LLC reports a 0% stake in Zentalis Pharmaceuticals, INC. |
02/14/2022 |
SC 13G/A
| Redmile Group, LLC reports a 3.8% stake in Allakos Inc. |
02/14/2022 |
SC 13G/A
| Redmile Group, LLC reports a 9.9% stake in Gritstone bio, Inc. |
02/14/2022 |
SC 13G/A
| Redmile Group, LLC reports a 4.6% stake in Celldex therapeutics, Inc. |
02/14/2022 |
SC 13G/A
| Redmile Group, LLC reports a 6.6% stake in Nurix therapeutics, Inc. |
02/14/2022 |
SC 13G/A
| Redmile Group, LLC reports a 6.7% stake in Repare therapeutics Inc. |
02/14/2022 |
SC 13G/A
| Redmile Group, LLC reports a 3.5% stake in TCR2 THERAPEUTICS INC. |
02/14/2022 |
SC 13G/A
| Redmile Group, LLC reports a 0% stake in DYNAMICS SPECIAL PURPOSE CORP. |
02/14/2022 |
SC 13G/A
| Redmile Group, LLC reports a 5% stake in Kymera Therapeutics, INC. |
02/14/2022 |
SC 13G/A
| Redmile Group, LLC reports a 8.6% stake in Pliant therapeutics, Inc. |
02/14/2022 |
SC 13G/A
| Redmile Group, LLC reports a 4.4% stake in REGENXBIO Inc. |
02/14/2022 |
SC 13G/A
| Redmile Group, LLC reports a 9.9% stake in HOOKIPA Pharma Inc. |
|
|
|